PFE

GFS Advisors LLC Sells 32,990 Shares of Pfizer Inc. (NYSE:PFE)

Source from : Defense World - 1 days ago

GFS Advisors LLC lessened its holdings in Pfizer Inc. (NYSE:PFE – Get Rating) by 17.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 157,198 shares ...See details»

Pfizer Inc. (NYSE:PFE) Shares Sold by Sippican Capital Advisors

Source from : Defense World - 1 days ago

Sippican Capital Advisors lessened its holdings in Pfizer Inc. (NYSE:PFE – Get Rating) by 0.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and ...See details»

Pfizer Inc.'s (NYSE:PFE) Earnings Are Not Doing Enough For Some Investors

Source from : YAHOO!Finance - 2 days ago

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 14x, you ...See details»

Pfizer (PFE) Seeks FDA Approval for Omicron Booster in Kids

Source from : YAHOO!News - 3 days ago

Pfizer (PFE) and partner BioNTech seek authorization from the FDA for using their bivalent COVID-19 booster vaccine in kids. The vaccine is already authorized for use in adolescents and adults.See details»

Pfizer CEO tests positive for COVID for a second time

Source from : Reuters - 6 days ago

Sept 24 (Reuters) - Pfizer Inc (PFE.N) Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. "I’m feeling well and symptom free," Bourla said in a statement.See details»

Are Pfizer Inc.'s (NYSE:PFE) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Source from : Nasdaq - 9 days ago

It is hard to get excited after looking at Pfizer's (NYSE:PFE) recent performance, when its stock has declined 8.9% over the past month. But if you pay close attention, you might find that its key ...See details»

Pfizer CEO Contracts COVID-19 Infection For Second Time

Source from : Yahoo News - 4 days ago

Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said he had tested positive for COVID-19. "I'm feeling well and symptom-free," 60-year-old Bourla said in a statement. In August, he contacted COVID and ...See details»

Pfizer: Covid-19 Treatment Isn't Only Expansion Opportunity On Deck

Source from : Seeking Alpha - 10 days ago

Pfizer Inc. (NYSE:PFE) is a great long-term biotech to own because it has two great long-term prospects that it is gearing towards. The first is the opportunity to increase sales with the use of ...See details»

Pfizer/BioNTech seek FDA nod for new COVID boosters for children

Source from : Reuters - 4 days ago

REUTERS/Hannah Beier/File Photo Sept 26 (Reuters) - Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron ...See details»

Pfizer Inc (PFE) Breaks Through Support at $44.85

Source from : MarketWatch - 10 days ago

Pfizer Inc (NYSE:PFE) has opened bearishly below the pivot of $45.37 today and has reached the first level of support at $44.85. Should the shares continue to fall, the support pivots of $44.27 and ...See details»

Pfizer Inc.'s (NYSE:PFE) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Source from : Yahoo - 10 days ago

It is hard to get excited after looking at Pfizer's (NYSE:PFE) recent performance, when its stock has declined 8.9% over the past month. But if you pay close attention, you might find that its key ...See details»

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Source from : Yahoo Finance - 2 days ago

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...See details»

Pfizer Requests Clearance for Children’s Covid-19 Booster

Source from : Wall Street Journal - 4 days ago

Pfizer Inc. and BioNTech SE asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years. The companies made the request on Monday as retooled shots ...See details»

Pfizer, BioNTech Ask FDA to Approve Booster for Children

Source from : MarketWatch - 5 days ago

By Dean Seal Pfizer Inc. and partner BioNTech SE have asked the U.S. Food and Drug Administration to approve the use of its Omicron-specific Covid-19 ...See details»